Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × ribociclib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Neoplasm Metastasis 5 Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Ovarian Neoplasms 3 Melanoma 3 Glioma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neuroblastoma 2 Neoplasms by Site 2 Lung Neoplasms 2 Glioblastoma 2 Breast Diseases 2 Brain Neoplasms 2 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Medulloblastoma 1 Locoregional Recurrence 1

Interventions

Cisplatin 7 Etoposide 6 fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Bleomycin 3 Automobiles 3 pralsetinib 2 pembrolizumab 2 etoposide phosphate 2 Sirolimus 2 Paclitaxel 2 Mesna 2 Drug Therapy 2 Carboplatin 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 tozuleristide 1 sodium thiosulfate 1 repotrectinib 1 pegfilgrastim 1 lutetium Lu 177 dotatate 1 durvalumab 1 cabozantinib 1 Vorinostat 1 Teniposide 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡